Rösch Sarah, Werner Claudia, Müller Frank, Walter Peter
Department of Ophthalmology, RWTH Aachen University, Pauwelsstr. 30, 52074, Aachen, Germany.
Clinical Department of Small Animals, University of Leipzig, Leipzig, Germany.
Graefes Arch Clin Exp Ophthalmol. 2017 Feb;255(2):317-331. doi: 10.1007/s00417-016-3531-7. Epub 2016 Nov 19.
Pilot study on the attempt to induce selective photoreceptor degeneration in the rabbit eye by intravitreal injection of MNU, facing the difficulties of the evaluation of retinal degeneration by different in-vivo and in-vitro methods in such a large eye animal model.
Eight pigmented Chinchilla Bastard rabbits were injected intravitreally with MNU (1 × 1mg/kg body weight (BW), 1 × 2mg/kg BW, 3 × 3mg/kg BW, 1 × 4mg/kg BW, 1 × 6mg/kg BW, and 1 × DMSO + PBS as control). One, 2, and 3 weeks after injection, the effects on the rabbit retina were examined in vivo using clinical observation (macroscopic images, funduscopy, weighing of the animals), measurement of intraocular pressure (IOP), full-field Electroretinography (ffERG), and spectral-domain Optical Coherence Tomography (sd-OCT). After 3 weeks follow-up, blood samples were taken to evaluate the general health status of the animals, and immunohistochemistry (IH) was performed on sections obtained from six different regions throughout the whole retina to evaluate MNU effects in more detail.
It was difficult to observe the effects of MNU on retinal structure by OCT in vivo. Only the temporal quadrant of the retina could be visualized. Therefore, it was indispensible to evaluate the effects of MNU on the retina in vitro by examining six areas of the retina using immunohistochemistry. Furthermore, immunohistochemistry plays a decisive role to evaluate the effects on retinal cells other than photoreceptors while in H&E staining, namely the cell count of the ONL can be observed. The results obtained in vivo and in vitro in this study mainly follow the results of a previous study in mice. The low doses of MNU (1, 2 mg/kg BW) had no effects on retinal function and morphology, while high doses (4, 6 mg/kg BW) led to retinal changes in combination with significant side-effects (e.g., cataractous changes). Injection of 3 mg/kg BW MNU induced selective photoreceptor degeneration. However, the degree of degeneration varied between different parts of the same retina and between retinae of different animals. In two of three animals, a complete loss of ERG potentials was observed. Negative effects on the contralateral eye or on general welfare of the animal were never observed.
In rabbits, the intravitreal injection of 3 mg/kg BW MNU leads to selective but inhomogeneous photoreceptor degeneration.
通过玻璃体腔内注射N-甲基-N-亚硝基脲(MNU)诱导兔眼选择性光感受器变性的初步研究,在如此大型的眼动物模型中面临着通过不同体内和体外方法评估视网膜变性的困难。
八只有色短尾绒鼠杂种兔经玻璃体腔内注射MNU(1×1mg/kg体重(BW)、1×2mg/kg BW、3×3mg/kg BW、1×4mg/kg BW、1×6mg/kg BW,以及1×二甲基亚砜+磷酸盐缓冲液作为对照)。注射后1、2和3周,使用临床观察(宏观图像、眼底镜检查、动物称重)、眼压(IOP)测量、全视野视网膜电图(ffERG)和光谱域光学相干断层扫描(sd-OCT)在体内检查对兔视网膜的影响。随访3周后,采集血样以评估动物的总体健康状况,并对从整个视网膜的六个不同区域获得的切片进行免疫组织化学(IH)检查,以更详细地评估MNU的作用。
在体内通过OCT很难观察到MNU对视网膜结构的影响。仅视网膜的颞侧象限可以可视化。因此,通过免疫组织化学检查视网膜的六个区域在体外评估MNU对视网膜的影响是必不可少的。此外,免疫组织化学在评估对除光感受器以外的视网膜细胞的影响方面起着决定性作用,而在苏木精-伊红(H&E)染色中,可以观察到外核层(ONL)的细胞计数。本研究在体内和体外获得的结果主要与先前在小鼠中的研究结果一致。低剂量的MNU(1、2mg/kg BW)对视网膜功能和形态没有影响,而高剂量(4、6mg/kg BW)导致视网膜改变并伴有明显的副作用(如白内障改变)。注射3mg/kg BW的MNU诱导选择性光感受器变性。然而,变性程度在同一视网膜的不同部位之间以及不同动物的视网膜之间有所不同。在三只动物中的两只中,观察到ERG电位完全丧失。从未观察到对侧眼或动物总体健康的负面影响。
在兔中,玻璃体腔内注射3mg/kg BW的MNU导致选择性但不均匀的光感受器变性。